Swiss National Bank lowered its position in Cameco Corporation (NYSE:CCJ - Free Report) TSE: CCO by 5.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,252,500 shares of the basic materials company's stock after selling 70,300 shares during the quarter. Swiss National Bank owned 0.29% of Cameco worth $105,163,000 as of its most recent SEC filing.
A number of other hedge funds have also made changes to their positions in the company. Abbington Investment Group acquired a new stake in Cameco during the third quarter worth approximately $6,506,000. Mirae Asset Global Investments Co. Ltd. lifted its position in shares of Cameco by 79.4% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 249,992 shares of the basic materials company's stock valued at $20,964,000 after acquiring an additional 110,629 shares during the period. Nwam LLC raised its holdings in Cameco by 11.7% during the second quarter. Nwam LLC now owns 81,129 shares of the basic materials company's stock worth $6,304,000 after buying an additional 8,519 shares during the last quarter. Hillsdale Investment Management Inc. grew its holdings in shares of Cameco by 165.1% during the second quarter. Hillsdale Investment Management Inc. now owns 169,448 shares of the basic materials company's stock valued at $12,593,000 after buying an additional 105,523 shares during the last quarter. Finally, NWF Advisory Services Inc. bought a new stake in shares of Cameco during the third quarter worth about $1,996,000. Institutional investors and hedge funds own 70.21% of the company's stock.
Wall Street Analyst Weigh In
A number of research analysts recently weighed in on CCJ shares. The Goldman Sachs Group reissued a "buy" rating and set a $131.00 price target on shares of Cameco in a research report on Wednesday, February 4th. Canadian Imperial Bank of Commerce increased their price objective on Cameco to $202.00 in a report on Monday. Glj Research reaffirmed a "buy" rating and set a $171.20 price target (up from $100.00) on shares of Cameco in a research report on Wednesday, February 18th. Zacks Research cut Cameco from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 18th. Finally, Raymond James Financial reiterated an "outperform" rating on shares of Cameco in a research note on Wednesday, January 14th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, Cameco presently has a consensus rating of "Moderate Buy" and a consensus price target of $150.40.
Get Our Latest Analysis on Cameco
Cameco Stock Up 3.4%
Shares of NYSE CCJ opened at $120.14 on Wednesday. The business has a 50-day simple moving average of $115.41 and a two-hundred day simple moving average of $97.15. Cameco Corporation has a 52 week low of $35.00 and a 52 week high of $135.24. The company has a market cap of $52.32 billion, a P/E ratio of 123.85 and a beta of 0.98. The company has a quick ratio of 1.68, a current ratio of 2.47 and a debt-to-equity ratio of 0.14.
Cameco (NYSE:CCJ - Get Free Report) TSE: CCO last issued its quarterly earnings data on Friday, February 13th. The basic materials company reported $0.36 EPS for the quarter, beating the consensus estimate of $0.29 by $0.07. Cameco had a net margin of 17.00% and a return on equity of 9.35%. The company had revenue of $874.57 million during the quarter, compared to analysts' expectations of $782.13 million. During the same quarter in the previous year, the company earned $0.36 earnings per share. Cameco's revenue for the quarter was up 1.5% on a year-over-year basis. Research analysts anticipate that Cameco Corporation will post 1.27 earnings per share for the current fiscal year.
Cameco Company Profile
(
Free Report)
Cameco Corporation NYSE: CCJ is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.
The company's operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cameco, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cameco wasn't on the list.
While Cameco currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.